Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) has earned a consensus rating of “Buy” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, one has assigned a buy recommendation and four have assigned a strong buy recommendation to the company.
Several brokerages recently weighed in on RBGLY. Sanford C. Bernstein downgraded shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 4th. Citigroup raised Reckitt Benckiser Group to a “strong-buy” rating in a report on Tuesday, October 1st. Barclays upgraded Reckitt Benckiser Group to a “strong-buy” rating in a report on Friday, October 4th. HSBC raised shares of Reckitt Benckiser Group from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. Finally, Hsbc Global Res raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a report on Wednesday, December 11th.
Read Our Latest Research Report on RBGLY
Reckitt Benckiser Group Stock Up 1.0 %
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Articles
- Five stocks we like better than Reckitt Benckiser Group
- ETF Screener: Uses and Step-by-Step Guide
- Bloom Energy: Powering the Future With Decentralized Energy
- What Makes a Stock a Good Dividend Stock?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- How to Use the MarketBeat Dividend Calculator
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.